Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vanguard Total Stock Market ETF (NY:VTI)

296.40 +2.83 (+0.96%)
Streaming Delayed Price Updated: 3:54 PM EDT, Jun 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vanguard Total Stock Market ETF

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
59 60 Next >
Better Buy: Vanguard Total Stock Market ETF vs. SPDR Portfolio S&P 1500 ETF
Via The Motley Fool
Topics ETFs Economy Stocks
Exposures Economy US Equities
Summit Therapeutics Stock Slumps After Partner Akeso Gets FDA Nod For Cancer Drug: Retail’s Optimistic
The company’s lead candidate, ivonescimab, aimed at treating certain cancers, was discovered by Akeso and is currently in multiple late-stage clinical trials. 
Via Stocktwits
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Centene Reports Upbeat Q1 Earnings But Higher Medicaid Costs Drag Stock: Retail Turns Bullish
The company now expects the health benefits ratio for the full year to be in the range of 88.9% to 89.5%, up from its previous guidance of 88.4% to 89%. 
Via Stocktwits
HCA Healthcare Reports Upbeat Q1 Earnings, Reaffirms 2025 Guidance: Retail Stays Optimistic
HCA Healthcare now expects full-year adjusted earnings per share of between $24.05 and $25.85, in line with an estimate of $24.96. 
Via Stocktwits
Topics World Trade
Exposures Tariff
AbbVie Reports Upbeat Q1 Earnings, Raises 2025 Earnings Forecast: Retail’s Elated
The company’s immunology drugs, Skyrizi and Rinvoq, marked significant revenue growth, offsetting a 50.6% decrease in net revenue from its arthritis drug, Humira. 
Via Stocktwits
Topics World Trade
Exposures Tariff
Aon Stock Falls Pre-Market On Q1 2025 Earnings Miss, Despite Reaffirming Full Year Outlook
Revenue increased 16% year-over-year to $4.73 billion but fell short of a Street estimate of $4.86 billion. 
Via Stocktwits
Topics Earnings Retirement
Exposures Financial Pension
Gilead Sciences Q1 Earnings Surpass Analyst Expectations, But Revenue Falls Short Of Estimates: Retail’s Optimistic
The company is eyeing FDA approval for its drug, lenacapavir, for HIV prevention by mid-June. 
Via Stocktwits
Topics Government Stocks
Exposures COVID-19 Political Product Safety
Google-Parent Alphabet's Stock Gets Price Target Hikes From JPMorgan, Goldman Sachs, Bank Of America Post Solid Q1
According to TheFly, JPMorgan expects continued solid search monetization and artificial intelligence innovation in an uncertain macro environment. 
Via Stocktwits
Topics Artificial Intelligence Government World Trade
Exposures Artificial Intelligence Political Tariff
Mark Zuckerberg's Meta Slashes VR Roles In Reality Labs: Retail Buzz Rises As Q1 Earnings Day Nears
The company reportedly said the layoffs were meant to help Oculus Studios work more efficiently on future mixed-reality experiences for its growing audience. 
Via Stocktwits
Topics Government Workforce World Trade
Exposures Layoff Political Tariff
Retail Investors Abuzz Over Apple's Reported Plan To Shift US iPhone Assembly To India
Apart from China, the iPhone is now made in India and Vietnam as well, although parts that go into the device come from across the globe. 
Via Stocktwits
Topics Economy Government World Trade
Exposures Political Supply Chain Tariff
Intel Joins Growing List Of Recession Worriers, Pins Gloomy Q2 Outlook To 'Increasingly Uncertain' Economic Landscape
CEO Lip-Bu Tan said the first quarter was a step in the right direction but added that there are no quick fixes. 
Via Stocktwits
Topics Artificial Intelligence Economy World Trade
Exposures Artificial Intelligence Economy Interest Rates
United Airlines Announces Investment In Aircraft Start-Up JetZero
United said that the investment includes a path to order up to 100 airplanes and an option for an additional 100. 
Via Stocktwits
Topics Economy
Exposures Economy
Halozyme Sues Merck Over Subcutaneous Keytruda Formulation, Seeks Injunctive Relief
Halozyme said that it believes the subcutaneous formulation of Merck's cancer medicine Keytruda infringes multiple patents that Halozyme filed beginning in 2011 to protect its groundbreaking MDASE... 
Via Stocktwits
Topics Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
Bristol Myers Reports Upbeat Q1 Earnings, Raises Full-Year Guidance: Retail’s Optimistic
The company now expects full-year diluted EPS in the range of $6.70 to $7.00, up from its previous guidance of $6.55 to $6.85. 
Via Stocktwits
Topics World Trade
Exposures Tariff
American Airlines Withdraws Full-Year Guidance Amid Economic Uncertainty, Reports Narrower Q1 Losses
CEO Robert Isom highlighted that the airline’s actions over the past several years to refresh its fleet, manage costs, and strengthen its balance sheet position it well for the uncertainty the industry... 
Via Stocktwits
Topics Earnings
Exposures Financial
Comcast Q1 2025 Earnings Beat Wall Street Estimates Despite Dip In Broadband Customers
CEO Brian L. Roberts highlighted that the company generated $5.4 billion of free cash flow and returned $3.2 billion to shareholders during the quarter. 
Via Stocktwits
Topics Earnings Stocks
Exposures Financial US Equities
Resmed Stock Rises Pre-Market On Upbeat Earnings, CEO Dismisses Tariff Impact: Retail Is Bullish
Revenue for the three months through the end of March rose 8% to $1.29 billion, in line with analyst estimates. 
Via Stocktwits
Topics Earnings Economy Government
Exposures Financial Political Supply Chain
Merck Reports Strong Q1 Earnings But Downgrades Full-Year Guidance: Retail Sentiment Brightens
Merck estimates that the impact of tariffs implemented to date will result in incremental costs of approximately $200 million. 
Via Stocktwits
Topics Government World Trade
Exposures Political Tariff
ServiceNow Stock Rallies After Q1 Beat, Positive Outlook: Retail Lauds String Of Upbeat Prints
CEO Bill McDermott said the company’s position as the “platinum standard for enterprise‑grade AI drove these outstanding first quarter results.” 
Via Stocktwits
Topics Artificial Intelligence Earnings
Exposures Artificial Intelligence Financial
Retail Bellwether P&G's Annual Forecast In Focus Ahead Of Q3 Print: Retail Hopes Low
Earlier this week, smaller rival Kimberly-Clark lowered its annual profit target and warned that tariffs would raise input costs. 
Via Stocktwits
Topics Government World Trade
Exposures Political Tariff
Texas Instruments Stock Jumps On Solid Q1 Print, Guidance, CEO Allays Tariff Concerns: Retail Is Excited
The company noted that all but one of its end markets grew sequentially, with personal electronics being the exception due to seasonality. 
Via Stocktwits
Topics Earnings Supply Chain World Trade
Exposures Financial Supply Chain Tariff
Chipotle Cuts Annual Same-Store Sales View On Uneven Demand, Tariff Hit: Retail Remains Optimistic
Chipotle said Trump’s tariffs might raise its cost of sales by about 0.5% this year, which could translate to tens of millions of dollars in extra spending. 
Via Stocktwits
Topics Economy Government World Trade
Exposures Economy Political Tariff
Tesla Executive Cancels Rome Conference Over Protests Against EV Maker, Says Report
Samantha Harris, Tesla's Global Sustainability Lead, was scheduled to speak at the Regenerative Future conference, planned for May 16-17 in Rome by the European Institute of Innovation and... 
Via Stocktwits
Topics Government
Exposures Political
Philip Morris Q1 2025 Beats Wall Street Estimates, Investors Cheer Improved 2025 Outlook
The company raised its 2025 earnings per share guidance to $7.36 to $7.49 compared to a previous forecast of $7.04 to $7.17. 
Via Stocktwits
Thermo Fisher Reports Strong Q1 Earnings But Revises Full-Year Guidance In Light Of Trump Tariffs: Retail’s Pessimistic
The company now expects 2025 revenue to be in the range of $43.3 billion to $44.2 billion and adjusted EPS to be in the range of $21.76 to $22.84, compared with its previous forecast of $23.10 to... 
Via Stocktwits
Topics Earnings Government World Trade
Exposures Financial Political Tariff
$1.5M Rich But Clueless – Couple With $82K Combined Income Says 'Need Help' After Winning Big, Reddit Explodes Over What They Should Do Next
Winning a large sum of money is a dream come true, but for many, it quickly turns into a financial puzzle. 
Via Benzinga
NextEra Energy Q1 2025 Earnings Beat Expectations, Backlog Totals 28 GW After ‘Strong Origination Quarter’
For 2025, NextEra expects adjusted earnings per share to be in the range of $3.45 to $3.70. 
Via Stocktwits
Topics Earnings Economy
Exposures Economy Financial
Boston Scientific Stock Jumps On Strong Q1 Earnings, Upbeat Full-Year Guidance: But Retail’s Unmoved
CEO Mike Mahoney said that the company remains “well-positioned” for the future after an “exceptional quarter.” 
Via Stocktwits
Exposures COVID-19 Product Safety
Novavax Signals Chances Of FDA Approval For Its COVID-19 Vaccine: But Retail Sentiment Wavers
The company announced on Wednesday that it had received formal communication from the FDA in the form of an information request for a “postmarketing commitment” to generate additional clinical data. 
Via Stocktwits
Topics Government
Exposures COVID-19 Political Product Safety
General Dynamics Q1 Results Beat Analyst Estimates Led By Significant Jump In Aerospace Earnings
Revenue rose 13.9% year-over-year to $12.22 billion and surpassed a Street estimate of $11.85 billion. 
Via Stocktwits
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
59 60 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.